Teladoc Health, Inc. Forecasted to Post FY2024 Earnings of ($1.00) Per Share (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) – Investment analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for Teladoc Health in a research report issued to clients and investors on Monday, April 29th. Cantor Fitzgerald analyst S. James forecasts that the health services provider will post earnings of ($1.00) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $22.00 price objective on the stock. The consensus estimate for Teladoc Health’s current full-year earnings is ($1.06) per share.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The firm had revenue of $646.13 million during the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.37) earnings per share.

A number of other brokerages have also commented on TDOC. Stifel Nicolaus decreased their price target on shares of Teladoc Health from $21.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, April 26th. Wells Fargo & Company decreased their target price on shares of Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Monday. SVB Leerink initiated coverage on Teladoc Health in a report on Monday, February 26th. They set a “market perform” rating and a $17.00 target price for the company. Canaccord Genuity Group cut their target price on shares of Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Friday, April 26th. Finally, Royal Bank of Canada cut their target price on Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, April 26th. Twelve research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $18.73.

Teladoc Health Stock Up 0.4 %

Shares of NYSE TDOC opened at $12.81 on Wednesday. Teladoc Health has a 12 month low of $12.53 and a 12 month high of $30.41. The firm has a market capitalization of $2.17 billion, a price-to-earnings ratio of -8.95 and a beta of 0.94. The company has a current ratio of 3.82, a quick ratio of 3.47 and a debt-to-equity ratio of 0.67. The business has a 50-day moving average of $14.54 and a 200-day moving average of $17.63.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of TDOC. ICA Group Wealth Management LLC purchased a new stake in Teladoc Health during the fourth quarter valued at approximately $28,000. Hexagon Capital Partners LLC increased its stake in Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after purchasing an additional 1,065 shares during the period. RIA Advisory Group LLC bought a new position in shares of Teladoc Health in the fourth quarter worth about $36,000. GAMMA Investing LLC purchased a new position in Teladoc Health in the 4th quarter worth about $41,000. Finally, Principal Securities Inc. purchased a new position in shares of Teladoc Health during the fourth quarter worth approximately $45,000. 76.82% of the stock is currently owned by institutional investors.

Insider Activity at Teladoc Health

In related news, COO Michael Willem Waters sold 4,523 shares of the firm’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $86,751.14. Following the transaction, the chief operating officer now directly owns 38,570 shares of the company’s stock, valued at approximately $739,772.60. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, COO Michael Willem Waters sold 4,523 shares of the stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $86,751.14. Following the completion of the sale, the chief operating officer now directly owns 38,570 shares of the company’s stock, valued at $739,772.60. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Laizer Kornwasser sold 7,882 shares of the company’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $151,176.76. Following the completion of the transaction, the insider now owns 57,223 shares of the company’s stock, valued at $1,097,537.14. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 135,441 shares of company stock worth $2,038,251. 0.95% of the stock is owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.